Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 15:366:577842.
doi: 10.1016/j.jneuroim.2022.577842. Epub 2022 Mar 5.

The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit

Pablo Diaz  1 , Marie Leveque  1 , Geoffroy Hautecloque  2 , François Sellal  2 , Olivier Augereau  3 , Livinia Lita  2 , Estelle Biegle  4 , Lounis Belilita  1 , Charles Bouterra  1 , Pierre Rerat  1 , Antonio Alvarez-Gonzalez  1 , Martin Martinot  5 , Victor Gerber  6
Affiliations

The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit

Pablo Diaz et al. J Neuroimmunol. .

Abstract

Various neurological complications have been described in COVID-19 patients, especially Guillain-Barre syndrome (GBS). The underlying mechanisms on the association between SARS-CoV-2 infection and GBS remain unclear, but several hypotheses have been proposed. It seems that post-SARS-CoV-2 GBS shares many characteristics with classic post-infectious GBS; however, it may occur in sedated and intubated patients hospitalized in the intensive care unit for SARS-CoV-2 acute respiratory distress syndrome, which presents challenges in the diagnosis and treatment of GBS. In this study, we describe three cases of post-SARS-CoV-2 GBS that were hospitalized in the intensive care unit.

Keywords: Acute inflammatory demyelinating polyneuropathy; COVID-19; Guillain–Barre syndrome; Intensive care unit; Miller Fischer syndrome; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Algorythm proposal for the management of a clinical suspicion of Guillain-Barre syndrome in SARS-CoV-2 patients under mechanical ventilation.
See this image and copyright information in PMC

References

    1. Araújo N.M., Ferreira L.C., Dantas D.P., Silva D.S., Dos Santos C.A., Cipolotti R., Martins-Filho P.R. First report of SARS-CoV-2 detection in cerebrospinal fluid in a child with Guillain–Barre syndrome. Pediatr. Infect. Dis. J. 2021;40:e274–e276. doi: 10.1097/INF.0000000000003146. - DOI - PubMed
    1. Curtis M., Bhumbra S., Felker M.V., Jordan B.L., Kim J., Weber M., Friedman M.L. Guillain–Barre syndrome in a child with COVID-19 infection. Pediatrics. 2021;147 doi: 10.1542/peds.2020-015115. - DOI - PubMed
    1. Dhar R., Stitt L., Hahn A.F. The morbidity and outcome of patients with Guillain-Barre syndrome admitted to the intensive care unit. J. Neurol. Sci. 2008;264:121–128. doi: 10.1016/j.jns.2007.08.005. - DOI - PubMed
    1. Finsterer J., Scorza F.A. Guillain-Barre syndrome in 220 patients with COVID-19. Egypt J. Neurol. Psychiatr. Neurosurg. 2021;57:55. doi: 10.1186/s41983-021-00310-7. - DOI - PMC - PubMed
    1. Finsterer J., Scorza F.A. Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome. J. Med. Virol. 2021 doi: 10.1002/jmv.27084. - DOI - PMC - PubMed